je.st
news
New Hepatitis C med approved
2014-10-11 07:16:24| Biotech - Topix.net
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved Harvoni , the first once-daily single tablet regimen for the treatment of chronic hepatitis C genotype 1 infection in adults. Harvoni combines the NS5A inhibitor ledipasvir with the nucleotide analog polymerase inhibitor sofosbuvir, approved under the tradename Sovaldi in December 2013.
Tags: med
approved
hepatitis
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||